Lineage Cell Therapeutics Inc (LCTX)
0.4016 x 10 0.4492 x 31
Post-market by (Cboe BZX)
0.4698 +0.0598 (+14.59%) 04/11/25 [NYSE Arca]
0.4016 x 10 0.4492 x 31
Post-market 0.4460 -0.0238 (-5.07%) 19:18 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,582 | -21,479 | -26,353 | -43,270 | -20,649 |
| Depreciation Amortization | 567 | 783 | 692 | 887 | 1,911 |
| Income taxes - deferred | N/A | -1,803 | N/A | N/A | -1,239 |
| Accounts receivable | 106 | -446 | 50,314 | -857 | 294 |
| Other Working Capital | -8,766 | -10,804 | 18,704 | 21,096 | 1,301 |
| Other Operating Activity | 3,583 | 5,183 | -42,298 | -1,417 | -1,371 |
| Operating Cash Flow | $-23,092 | $-28,566 | $1,059 | $-23,561 | $-19,753 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18 | 196 | N/A | N/A | N/A |
| PPE Investments | -565 | -674 | -413 | -340 | -41 |
| Purchase Of Investment | -8,761 | -16,403 | -53,412 | N/A | N/A |
| Sale Of Investment | 7,000 | 63,330 | 7,666 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 10,085 | 13,079 |
| Investing Cash Flow | $-2,308 | $46,449 | $-46,159 | $9,745 | $13,038 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -54 | -54 | -32 | -20 | -26 |
| Common Stock Issued | 36,105 | 6,514 | 1,787 | 38,105 | 5,127 |
| Common Stock Repurchased | -23 | -37 | -17 | -54 | -27 |
| Other Financing Activity | -171 | 0 | -106 | -1,101 | 24,791 |
| Financing Cash Flow | $35,857 | $6,423 | $1,632 | $36,930 | $29,865 |
| Exchange Rate Effect | -95 | -250 | -873 | -20 | -63 |
| Beginning Cash Position | 35,992 | 11,936 | 56,277 | 33,183 | 10,096 |
| End Cash Position | 46,354 | 35,992 | 11,936 | 56,277 | 33,183 |
| Net Cash Flow | $10,362 | $24,056 | $-44,341 | $23,094 | $23,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,092 | -28,566 | 1,059 | -23,561 | -19,753 |
| Capital Expenditure | -565 | -674 | -413 | -340 | -64 |
| Free Cash Flow | -23,657 | -29,240 | 646 | -23,901 | -19,817 |